Hence the inhibition of the PI3K/Akt pathway may result in the activation of the FOXO3a transcription factor, which may then induce the AR gene expression to protect cells from apoptosis of LNCaP prostate cancer cells. This evidence concerns the gene FOXO3 and prostate cancer.